These 2 stocks are still on our shopping list, and what Eli Lilly needs to deliver on earnings
Investment
CNBC

These 2 stocks are still on our shopping list, and what Eli Lilly needs to deliver on earnings

August 6, 2025
06:44 PM
4 min read
AI Enhanced
investmentstockstradingtechnologyconsumer discretionarymarket cyclesseasonal analysismarket

Key Takeaways

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

Article Overview

Quick insights and key information

Reading Time

4 min read

Estimated completion

Category

investment

Article classification

Published

August 6, 2025

06:44 PM

Source

CNBC

Original publisher

Key Topics
investmentstockstradingtechnologyconsumer discretionarymarket cyclesseasonal analysismarket

Every weekday, the CNBC with Jim Cramer releases the stretch — an actionable afternoon , time for the last hour of trading on Wall Street. : Stocks are nicely higher on Wednesday with the S & P 500 rebounding from a slight dip in the prior session

Apple is one of the big gainers in the session after the White House confirmed to CNBC that the company plans to add another $100 billion to its previous $500 billion manufacturing investment pledge to the United States over the next four years

Apple was also reportedly spared from the recent tariff escalation on goods from India

That one-two punch of good news has sent Apple s up nearly 6% and on pace for their third session over the past year

Still waiting : It's been one week, but we are still looking to buy some Starbucks and Palo Alto Networks s at these levels when our trading restrictions allow

The way our restrictions work is that we're unable to trade any stock that Jim Cramer mentions on CNBC for the next 72 hours

Both stocks got dinged last week: Starbucks sold off on earnings despite CEO Brian Niccol explaining that the coffee chain's turnaround plan was ahead of schedule

And Palo Alto Networks was slammed after it said it was buying CyberArk for $25 billion

This is the largest acquisition in the company's history, which naturally brings some execution risk

However, CEO Nikesh Arora is known for his deal-making

When he says the identity security market is inflecting , making now the best time to enter the category, we want to be there with him

With a more than 1% gain Wednesday afternoon, Palo Alto s are on track to snap a six-session losing streak that began July 29, the day that The Wall Street Journal first reported on acquisition talks with CyberArk

Up next : Companies reporting after the closing bell on Wednesday include retail darling AppLovin , language learning app Duolingo , cybersecurity vider Fortinet , Airbnb , coffee chain Dutch Bros , and sportsbook DraftKings

Meanwhile, name Eli Lilly is set to report earnings before the opening bell on Thursday, and we're looking for combined revenue from Mounjaro and Zepbound to come in above the FactSet consensus estimate $7.73 billion

A raise would be a plus, but Eli Lilly will have to at least maintain its full-year guidance to ease concerns a potential slowdown in the GLP-1 market, which Novo Nordisk highlighted last week

We trimmed our Lilly position off that Novo news as a hedge against slowing trends

Other companies scheduled to report are electricity vider Vistra , HBO parent Warner Bros

Discovery , Band-Aid owner Kenvue , and aircraft parts maker Parker-Hannifin

On the data side, we'll be on the lookout for weekly jobless claims

This report suddenly has a lot more importance to it ing last week's awful jobs number. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a r to the CNBC with Jim Cramer, you will receive a trade alert before Jim makes a trade

Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio

If Jim has talked a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade

THE ABOVE INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER

NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION VIDED IN CONNECTION WITH THE

NO SPECIFIC OUTCOME OR FIT IS GUARANTEED.